Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

Promoter reporter studies for SF-1 regulating the human <i>BDNF</i> promoter I and comparative studies of specific <i>NR5A1</i> mutations on <i>BDNF</i> promoter activity. by Jana Malikova (615672)

Subjects:

Genetic information on 5 subjects carrying <i>NR5A1</i> mutations. by Jana Malikova (615672)

Subjects:

Children’s Quality of Life Based on the KIDSCREEN-27: Child Self-Report, Parent Ratings and Child-Parent Agreement in a Swedish Random Population Sample by Anne H. Berman (615685)

“…<div><p>Background</p><p>The KIDSCREEN-27 is a measure of child and adolescent quality of life (QoL), with excellent psychometric properties, available in child-report and parent-rating versions in 38 languages. …”

Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice. by Sheona Watson-Scales (586942)

Data_Sheet_1_Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer’s Disease Patients.pdf by Felix Dinkel (9176504)

“…Impaired gamma secretase function favors production of longer beta-amyloid species in PS1 FAD. The PS1 E280A mutation is the largest FAD kindred under study. …”

DataSheet_1_Vascular inflammation on a chip: A scalable platform for trans-endothelial electrical resistance and immune cell migration.pdf by Haley Ehlers (14495279)

“…We developed a scalable platform for parallel measurements of trans epithelial electrical resistance (TEER) in 64 perfused microfluidic HUVEC tubules under inflammatory conditions. …”

Decreased Aβ oligomer immunoreactivity in APPxPS1 mice after treatment with hNGFP61S/R100E: polyclonal pAb A11 antibody. by Simona Capsoni (161132)

TachypleginA treatment causes a decrease in the motor activity of the TgMyoA motor complex. by Aoife T. Heaslip (207534)

I348T increases H77 entry dependency on SR-BI, while T385P decreases H77 entry dependency on SR-BI. by Christina Holmboe Olesen (11154333)

DataSheet1_Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole.docx by Su-jie Jia (10869666)

“…The mutation of CYP3A5 has no significant effect. Furthermore, CYP2C19*17 mutants could strengthen the effects of glucocorticoids and decrease VRC C_min/dose to a larger extent.…”

Table_1_Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment.DOCX by Jörg Wissel (5748323)

“…We hypothesized that the early-start group would show a larger benefit (decrease) as assessed by the modified Ashworth scale (MAS, primary endpoint) on elbow plus wrist flexors compared with the late-start group.…”

Clinical outcome (3-month mean drop in HbA1c) by incentive group. by Leonard E. Egede (8097272)

Subjects:

Cost by incentive group. by Leonard E. Egede (8097272)

Subjects:

Sample demographics for study overall and by intervention group. by Leonard E. Egede (8097272)

Subjects:

Bootstrap analysis of Incremental Cost Effectiveness Ratios (ICERs). by Leonard E. Egede (8097272)

Subjects:

CONSORT flow diagram. by Leonard E. Egede (8097272)

Subjects:

Seven out of the 11 human cytidine deaminases are more highly expressed in tumor versus normal tissue and their higher expression is correlated with a decrease in survival. by Mason A. McCool (11889842)

“…<p>(A) Higher expression of 8 out of the 11 human cytidine deaminases correlates with decreased survival probability. …”

Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion by Zhiqiang Xia (764303)

The Use of Alendronate Is Associated with a Decreased Incidence of Type 2 Diabetes Mellitus—A Population-Based Cohort Study in Taiwan by Ding-Cheng Chan (549939)